|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑
/ ]+ ^4 v+ Z5 F1 M1 a: \6 G" M8 B% C3 e/ m7 c1 N! X7 n4 A8 H# x
今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了1 S4 s+ W. b) i4 K
* @# ~( p+ r, r; e3 g! b' S/ o
头颈肿瘤BU入选ASCO 2025的研究
3 I `# I- C" [$ P: THot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
( A) o8 K4 n3 h3 E4 F肿瘤内科-头颈肿瘤科姜愚团队
2 P( Q" u! n. j/ W- ^6 O
# j2 G& e6 Y0 Q" D8 z& UNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.
E/ _: }4 }' _3 _% G: u* K肿瘤内科-头颈肿瘤科刘磊团队$ F6 E% q& S! I5 f
2 t8 F1 A9 ?8 M! _7 _A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.
# z, S% |( X+ g9 s: B q肿瘤内科-头颈肿瘤科刘磊团队+ L2 w! u' |6 r: Z
$ F* P% V9 e, D* @& ^# c! x
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.2 v5 ]/ a0 v2 g8 s9 L( t
肿瘤内科-头颈肿瘤科刘磊团队% P# P' R9 \5 C3 g+ f
' F- b1 Y. n: I+ ?ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
: G- A5 c' `3 v7 w" n/ c4 a# |' _# Z肿瘤内科-头颈肿瘤科姜愚团队$ u% g& c0 A2 g7 h. k0 e
|
|
[复制链接]
发表于 2025-5-9 16:51:15
